Pharmaids Pharmaceuticals Limited (BOM:524572)

Pharmaids Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	2.39	21.45	48.04	127.54	4.07	2
Short-Term Investments	-	-	-	33.05	-	-
Cash & Short-Term Investments	2.39	21.45	48.04	160.59	4.07	2
Cash Growth	-91.44%	-55.36%	-70.09%	3841.48%	103.44%	819.72%
Accounts Receivable	86.95	31.28	26.79	20.54	13.39	2.77
Receivables	86.95	31.28	26.79	20.54	13.39	2.77
Inventory	40	121.84	35.91	-	8.88	3.69
Prepaid Expenses	-	4.02	1.57	-	-	-
Other Current Assets	112.43	44.48	23.01	2.02	0.34	0.11
Total Current Assets	241.76	223.07	135.32	183.16	26.68	8.57
Property, Plant & Equipment	264.81	491.8	384.59	21.06	4.81	4.9
Goodwill	314.17	314.17	314.17	-	-	-
Other Intangible Assets	-	5.45	5.45	-	-	-
Long-Term Accounts Receivable	-	-	-	-	14.16	7.58
Long-Term Deferred Tax Assets	102.44	105.03	66.68	27.08	3.56	3.51
Long-Term Deferred Charges	-	-	-	1.21	-	-
Other Long-Term Assets	61.21	59	7.21	0.85	61.92	66.59
Total Assets	984.38	1,199	913.41	245.85	111.12	91.15
Accounts Payable	132.97	163.21	51.18	18.83	23.06	5.02
Accrued Expenses	0.02	6.58	4.62	0.28	-	-
Short-Term Debt	-	40.57	11.53	-	-	-
Current Portion of Long-Term Debt	45.19	10.06	6.14	-	-	-
Current Portion of Leases	6.41	7.93	7.13	-	-	-
Current Income Taxes Payable	-	0.26	-	-	-	-
Other Current Liabilities	113.57	58.53	35.16	2.14	1.35	0.87
Total Current Liabilities	298.16	287.15	115.76	21.25	24.41	5.89
Long-Term Debt	129.1	301.84	35.85	-	-	-
Long-Term Leases	20.62	29.35	24.68	-	-	-
Pension & Post-Retirement Benefits	1.4	7.78	6.15	-	-	-
Other Long-Term Liabilities	22	22	26	-0	-	-0
Total Liabilities	471.28	648.11	208.44	21.25	24.41	5.89
Common Stock	352.68	352.68	352.68	214.44	102.69	102.69
Additional Paid-In Capital	-	505.75	505.75	104.24	-	-
Retained Earnings	-	-266.77	-139.3	-98.89	-23.33	-24.78
Comprehensive Income & Other	166.51	1.55	1.34	4.81	7.36	7.36
Total Common Equity	519.19	593.2	720.47	224.6	86.72	85.26
Minority Interest	-6.09	-42.79	-15.5	-	-	-
Shareholders' Equity	513.11	550.42	704.97	224.6	86.72	85.26
Total Liabilities & Equity	984.38	1,199	913.41	245.85	111.12	91.15
Total Debt	201.32	389.75	85.33	-	-	-
Net Cash (Debt)	-198.93	-368.3	-37.29	160.59	4.07	2
Net Cash Growth	-	-	-	3841.48%	103.44%	819.72%
Net Cash Per Share	-5.27	-10.44	-1.64	12.45	0.40	0.19
Filing Date Shares Outstanding	35.43	35.27	35.27	21.49	10.31	10.31
Total Common Shares Outstanding	35.43	35.27	35.27	21.49	10.31	10.31
Working Capital	-56.4	-64.07	19.56	161.91	2.27	2.69
Book Value Per Share	14.65	16.82	20.43	10.45	8.41	8.27
Tangible Book Value	205.03	273.59	400.85	224.6	86.72	85.26
Tangible Book Value Per Share	5.79	7.76	11.37	10.45	8.41	8.27
Land	-	254.5	178.22	-	-	-
Buildings	-	7.72	6.08	-	-	-
Machinery	-	184.48	116.88	-	5.09	5.09
Construction In Progress	-	45.3	70.01	-	4.5	4.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.